Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Jabak Toured West Bekaa Hospitals: I Apologize on behalf of the Lebanese State for Failing to Fulfill its Responsibilities towards the Region's Residents

 
Minister of Public Health Dr. Jamil Jabak visited the governmental hospitals located in West Bekaa as part of his tour of the governmental health facilities in Lebanon, starting with Kherbet Kanafar hospital.
 
“We will not accept to see any hospital suffer from lack of financial ceiling or shortage of medical equipment, since it is vital and crucial to any medical facility. I promise to establish a new building to ensure maximum availability of medical services,” Jabak stated after he was briefed on the situation of the hospital by its director Imad Ghantous.
 
Later in the day, Jabak visited Machgara Governmental hospital, where he was received by political, social and medical figures. After he toured the departments of the hospital, Dr. Abbas Rida explained the situation of the hospital that was established in 1996, but now lacks the financial and technical assistance in the absence of the financial ceiling.
 
Minister Jabak expressed anger at what he saw at the hospital, as he continued his visit to the departments. “I was shocked at the situation of this Lebanese governmental hospital that suffers from neglect and shortage in terms of equipment,” Jabak added.
 
Minister Jabak promised to secure an advance payment for the launch of the project as a preliminary step and raise the financial ceiling of the hospital.
 
‘I would like to apologize on behalf of the Lebanese State for failing to fulfill its responsibilities towards the region's residents,” Jabak said.
 
Jabak concluded his tour in West Beqaa Hospital in Somhor, inspecting its departments and praising the role of the Islamic health committee in the improvement of the medical work in this vital facility.
    1
ATC Name B/G Ingredients Dosage Form Price
C08DA01 ISOPTIN B Verapamil (HCl) - 80mg 80mg Tablet, film coated 397,704 L.L
R07AA INFASURF B Calfactant - 210mg/6ml 35mg/ml Injectable suspension 40,596,749 L.L
C08DA01 ISOPTIN SR B Verapamil (HCl) - 240mg 240mg Tablet, film coated, prolonged release 1,128,821 L.L
R07AA INFASURF B Calfactant - 105mg/3ml 35mg/ml Injectable suspension 23,344,161 L.L
R03AK08 INUVER B Formoterol fumarate - 6mcg/dose, Beclometasone dipropionate - 100mcg/dose Inhalation solution 3,225,222 L.L
R03AK08 INUVER NEXTHALER B Formoterol fumarate dihydrate - 6mcg/dose, Beclometasone dipropionate - 100mcg/dose Inhalation powder 4,031,528 L.L
D06BA51 IALUGEN PLUS B Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 2mg/g Cream 1,064,323 L.L
D06BA51 IALUGEN PLUS B Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 0.5mg/g Gauze 1,463,444 L.L
J01DH03 INVANZ B Ertapenem - 1g 1g Injectable concentrated powder for solution 3,785,604 L.L
L04AX01 IMURAN B Azathioprine - 50mg 50mg Tablet 2,030,546 L.L
S01BA15 ILUVIEN B Fluocinolone acetonide - 0.19mg 0.19mg Implant 629,182,630 L.L
L04AX01 IMURAN B Azathioprine - 50mg 50mg Tablet 2,030,546 L.L
S01BC01 INDOCOLLYRE B Indometacine - 5mg/5ml 0.1% Drops 408,528 L.L
A07DA03 IMODIUM B Loperamide HCl - 2mg 2mg Capsule 138,416 L.L
A07DA03 IMODIUM INSTANTS B Loperamide HCl - 2mg 2mg Tablet, orodispersible 451,531 L.L
A07FA51 INFLORAN B Bifidobacterium infantis - 1milliard, Lactobacillus acidophilus - 1milliard Capsule 647,732 L.L
L04AX06 IMNOVID B Pomalidomide - 2mg 2mg Capsule, hard 290,515,206 L.L
L04AX06 IMNOVID B Pomalidomide - 4mg 4mg Capsule, hard 290,515,206 L.L
M01AB01 INDOCID B Indometacin - 100mg 100mg Suppository 424,910 L.L
N02CC01 IMIGRAN B Sumatriptan (succinate) - 100mg 100mg Tablet, film coated 616,824 L.L
N02CC01 IMIGRAN B Sumatriptan (succinate) - 50mg 50mg Tablet, film coated 378,964 L.L
L01EA05 ICLUSIG B Ponatinib - 15mg 15mg Tablet, film coated 103,555,839 L.L
L01EA05 ICLUSIG B Ponatinib - 45mg 45mg Tablet, film coated 207,092,651 L.L
L01EB01 IRESSA B Gefitinib - 250mg 250mg Tablet, fim coated 135,027,509 L.L
N05AX13 INVEGA B Paliperidone - 9mg 9mg Tablet, prolonged release 5,825,557 L.L
N05AX13 INVEGA B Paliperidone - 3mg 3mg Tablet, prolonged release 2,912,107 L.L
N05AX13 INVEGA B Paliperidone - 6mg 6mg Tablet, prolonged release 5,825,557 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 100mg 100mg Injectable suspension, prolonged release 19,068,992 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 75mg 75mg Injectable suspension, prolonged release 15,240,595 L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 50mg 50mg Injectable suspension, prolonged release 9,661,754 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2026